Check your eligibility
A short, private assessment tells us whether the programme is right for you.
What you unlock
- 2-minute online assessment
- Instant eligibility result
- No commitment, fully private
Menu
Takes about two minutes.
Our story
Karespot is a doctor-led weight-loss service in India.
Chapter 01 · Why we started
It's biology. We started Karespot to make real, medical care for it something people can actually reach.
For millions of people, weight is driven by appetite, metabolism and constant food noise, not a lack of effort.
Effective treatment existed, but it was hard to access, poorly explained, and priced as a luxury few could reach.
We built Karespot so good care isn't a premium privilege. It's accessible to everyone choosing to reclaim their life.
Why Karespot existsGood care shouldn't be a privilege. It should be where every journey begins.
Chapter 02 · The Kare advantage
The Kare advantage is a holistic lens on weight loss. We believe medicine is a tool, a powerful one, but you are the true protagonist of your journey. Our role is to empower you and support you at every step, so you never feel alone at any stage.
The programme was designed by practising doctors: internal medicine physicians working in metabolic health, alongside a dietician, a psychologist and health coaches. Clinical thinking, built for how people actually live. Meet the doctors behind Karespot.
What the medicine does: Reduces appetite, Quietens food noise, Slows gastric emptying. What it cannot do: Choose what you eat, Build strength, Handle stress and sleep. Treatment ends: Medicine is temporary. Your team works here: Doctor, dietician, psychologist, coach.
What the medicine does
What it cannot do
Treatment ends
Medicine is temporary
Your team works here
Doctor, dietician, psychologist, coach
What stays with you
Habits, strength and knowing how your own body works
Chapter 03 · The pillars
Medication is one part of the picture. These are the principles the rest of the programme is built on.
Care that lasts
Built on clinical evidence
Weight loss
Specialist Doctor-led
Muscle-smart
Personalised
Your choice
Zero kickbacks
Built for India
Swipe to explore · tap a card to read more.
Chapter 04 · Holistic Kare
Holistic Kare means supporting your whole life, not just handing over a prescription. You have a team around you at every step, and the longer they're with you, the stronger the change becomes.
Personalised eating guidance from a qualified dietician.
Support for sleep, stress and the habits that shape eating.
Doctors help you manage any side effects safely.
A coach to guide you and keep you on track, week to week.
From your first assessment to lasting results: a guided path designed around you.
A short, private assessment tells us whether the programme is right for you.
What you unlock
Meet one-on-one with a licensed doctor who designs a plan built around your body.
What you unlock
Begin your treatment with support that stays with you at every step.
What you unlock
Eligibility & safety
Weight-loss medication is prescribed to people who meet the approved criteria:
30+
BMI of 30 or above
On its own, with no other condition required.
Why India's thresholds are lower
BMI reads differently for Indian bodies. South Asians carry more visceral fat and develop diabetes, hypertension and fatty liver at lower body weights, so Indian guidance flags overweight from a BMI of just 23 and obesity from 25 (against the international standard of 30) and supports treating at lower thresholds than Western guidelines. That is why your doctor reads your BMI against India-specific cut-offs, not just the international scale.
How we keep it safe
Weight-loss medication is only prescribed under the supervision of, and after a consultation with, an internal medicine doctor. Before anything is prescribed, a detailed medical history is taken to assess whether the medicine is safe and right for you.
If it isn't right for you, we will tell you.
The prescribing thresholds use standard BMI. Indian cut-offs, which flag risk earlier, are marked on the scale for context, because metabolic risk in Indian adults begins at lower BMIs.
BMI is a screening measure, not a diagnosis. It can misread muscular or older bodies, and your doctor weighs it alongside waist, history and metabolic markers. Zone boundaries follow the Endocrine Society of India's 2025 guidance [3].
Chapter 06 · Muscle-smart
A lot of the weight people lose on GLP-1 medicines can come from muscle, not just fat. [1] So our protocols are designed by a multidisciplinary clinical team to help you get the most from your fat loss while protecting muscle.
What the scale hides
Illustrative comparison of the composition of weight lost. GLP-1 alone: part of the loss is fat lost and part is muscle lost. The Karespot way: the loss is fat lost while muscle protected.
Illustrative, not to scale. A meaningful share of weight lost on GLP-1 medicines alone can be lean muscle. [1] High-protein nutrition and strength-based activity help protect it.
Oversee your treatment, your dosing and your overall health.
Guides safe, effective use of GLP-1 medicines.
Builds the high-protein plan that helps protect lean muscle.
Help protect muscle, strength and joints.
The long term
Karespot was built by doctors with one aim: to help you keep the weight off, not just lose it.
Obesity is a chronic condition, and when treatment and support stop abruptly, much of the lost weight is often regained. [2] That's why Karespot is built for the long term: ongoing medical support paired with our muscle-smart, holistic approach, so your results are more likely to last.
Illustrative comparison. With ongoing support: about 85 per cent of the lost weight stays off and about 15 per cent returns. When support stops: about 35 per cent stays off and about 65 per cent returns.
Why ongoing support matters
With ongoing support
Treatment and coaching continue
When support stops
Medication ended abruptly
Illustrative, not to scale. With ongoing treatment and support most of the lost weight tends to be kept off, though some regain is normal [4], while much more is regained when treatment and support stop. [2]
The people
Karespot is built around qualified clinicians: prescribing doctors, medical reviewers, a registered dietician, a psychologist, and experienced advisors.
Internal Medicine
Read profile
Consulting Physician
Read profile
Consulting Physician
Read profileOrthopaedics and Spine Consultant
Medical Reviewer
Read profile
Medical Content Author
Read profile
Registered Dietician
Read profile
Psychologist
Read profile
Consulting Dermatologist & Advisor
Read profile
Advisor
Read profile
Strategy & Operations Advisor
Read profile
Advisor
Read profileSwipe to browse the team
Every article on Karespot is written or reviewed by a named clinician, and every prescription comes from a registered doctor.
FAQs
Karespot is a doctor-led weight-loss service in India that combines prescription GLP-1 medication with personalised health coaching, all supervised by registered doctors. Every patient is seen by an NMC-registered doctor, and the programme also includes a registered dietician, a clinical psychologist and a health coach.
Weight-loss medication is prescribed to people with a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related health condition such as type 2 diabetes, prediabetes, high blood pressure, abnormal cholesterol, fatty liver or obstructive sleep apnoea.
Because South Asians develop metabolic disease at lower body weights, Indian guidance flags overweight from a BMI of 23 and obesity from 25, so your BMI is always read against India-specific cut-offs. Eligibility is confirmed by a doctor during your consultation; meeting a BMI threshold does not automatically mean medication is right for you.
Check your BMINo. Karespot is brand-agnostic. Our plans include both innovator medicines and Indian biosimilars, and no incentives, commissions or kickbacks are paid to any Karespot care provider to promote a particular medicine, brand or plan.
Your doctor explains the differences in cost and evidence, and the choice is made with you.
Treatment is only prescribed after a doctor reviews your health, and our team supports you and monitors your progress throughout. GLP-1 medicines are prescription-only and are used under medical supervision.
The most common side effects are gastrointestinal: nausea, vomiting, constipation and reflux. They are usually worst in the first weeks and after each dose increase, which is why the dose starts low and is raised slowly.
Yes. A registered doctor must assess your health before any medication is prescribed. You start with a short online eligibility check, followed by a consultation with an internal medicine doctor.
Karespot offers clinically proven GLP-1 medicines such as semaglutide (Wegovy) and tirzepatide (Mounjaro) where appropriate, alongside coaching for nutrition and habits. Your doctor recommends what is suitable for you based on your health profile and weight goals.
Often, yes, unless the underlying habits and metabolic drivers have been addressed. Obesity is a chronic, relapsing condition, and studies show a significant proportion of lost weight is regained in the year after GLP-1 treatment stops.
This is exactly why Karespot pairs medication with dietician coaching, psychologist support and strength-based activity, so that when the medication ends, the habits and the muscle remain.
Yes. Karespot works through telehealth, so you can access consultations and treatment from anywhere in India. Medication is delivered in plain, unmarked packaging with no identifying labels on the outside.
Still have a question?
Speak to a Karespot doctor and get a clear answer about whether treatment is right for you.
Check your eligibilityEvidence
Every claim on this page is traceable to one of the sources below, and each reference links on to the original.
Neeland IJ, et al. Changes in lean body mass with GLP-1-based therapies and mitigation strategies. Diabetes, Obesity and Metabolism, 2024.
Supports the muscle-loss figures in the Muscle-smart chapter.
Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism, 2022;24(8):1553-1564.
Supports the weight-regain figures shown when treatment and support stop abruptly.
ESI Clinical Practice Guidelines for the Evaluation and Management of Obesity in India, 2025 update.
Source for the Indian BMI cut-offs (overweight ≥ 23, obesity ≥ 25) shown on the BMI scale, and for treating obesity earlier in Indian adults.
Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: the Look AHEAD study. Obesity (Silver Spring), 2014;22(1):5-13.
Supports long-term weight maintenance with ongoing support.
Management of obesity in adult Asian Indians.
Context for why Asian Indians develop metabolic disease at lower BMIs and why Indian cut-offs are set lower than international ones.
Ask us anything before you decide. A real person from the Karespot team will answer, not a bot.
We usually reply within a few hours